Notification
No new Notification messages
Enviro Infra Engineers IPO is Open!
Apply for the Enviro Infra Engineers IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
windlas biotech limited stock

WINDLAS BIOTECH LIMITED Share Price

961.7 35.10 (3.78%)
Nov 22 2024 03:30 PM Pharmaceuticals NSE: WINDLAS

WINDLAS BIOTECH LIMITED Share Price Update

As of the latest trading session, WINDLAS BIOTECH LIMITED share price is currently at 961.7, which is up by 35.10 from its previous closing. Today, the stock has fluctuated between 905.25 and 992.90. Over the past year, WINDLAS BIOTECH LIMITED has achieved a return of 113.37 %. In the last month alone, the return has been -7.61 %. Read More...

WINDLAS BIOTECH LIMITED Performance

Day Range

Low905.25 High992.90
961.70

52 Week Range

Low 400.10 High 1198.25
961.70

WINDLAS BIOTECH LIMITED Share Price

5366

543329

WINDLAS

img img img img
No Data Available

Open Price

922.00

Prev. Close

926.60

Volume (Shares)

72427.00

Total traded value

696.53

Upper Circuit

1111.90

Lower Circuit

741.30

Note: The current prices & values are delayed, Login to your account for live updates.

WINDLAS BIOTECH LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 2000.19
PE Ratio (TTM) 31.61
Book Value / Share 225.62
Beta 0.81
ROE 13.63%
EPS (TTM) 29.27
Dividend Yield 0.59%
Net Profit Qtr (Cr) 15.66

WINDLAS BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 187.00
Operating Expense 171.54
Net Profit 15.66
Net Profit Margin (%) 8.37
Earnings Per Share (EPS) 7.49
EBITDA 27.89
Effective Tax Rate (%) 22.81
Particulars JUN 2024 (Values in Cr)
Revenue 175.15
Operating Expense 160.97
Net Profit 13.48
Net Profit Margin (%) 7.69
Earnings Per Share (EPS) 6.47
EBITDA 25.00
Effective Tax Rate (%) 26.37
Particulars MAR 2024 (Values in Cr)
Revenue 171.29
Operating Expense 153.17
Net Profit 16.95
Net Profit Margin (%) 9.89
Earnings Per Share (EPS) 8.15
EBITDA 26.38
Effective Tax Rate (%) 24.86
Particulars DEC 2023 (Values in Cr)
Revenue 162.21
Operating Expense 145.58
Net Profit 15.10
Net Profit Margin (%) 9.30
Earnings Per Share (EPS) 7.26
EBITDA 23.50
Effective Tax Rate (%) 23.77
Particulars SEP 2023 (Values in Cr)
Revenue 152.67
Operating Expense 137.60
Net Profit 14.03
Net Profit Margin (%) 9.18
Earnings Per Share (EPS) 6.75
EBITDA 21.93
Effective Tax Rate (%) 23.37
Particulars MAR 2024 (Values in Cr)
Revenue 630.96
Operating Expense 567.40
Net Profit 58.14
Net Profit Margin (%) 9.21
Earnings Per Share (EPS) 27.95
EBITDA 91.55
Effective Tax Rate (%) 24.51
Particulars MAR 2023 (Values in Cr)
Revenue 513.08
Operating Expense 466.00
Net Profit 42.64
Net Profit Margin (%) 8.31
Earnings Per Share (EPS) 19.71
EBITDA 70.21
Effective Tax Rate (%) 25.25
Particulars MAR 2022 (Values in Cr)
Revenue 465.93
Operating Expense 426.60
Net Profit 38.56
Net Profit Margin (%) 8.27
Earnings Per Share (EPS) 18.81
EBITDA 59.61
Effective Tax Rate (%) 16.24
Particulars MAR 2021 (Values in Cr)
Revenue 427.60
Operating Expense 387.17
Net Profit 5.01
Net Profit Margin (%) 1.17
Earnings Per Share (EPS) 2.75
EBITDA 25.43
Effective Tax Rate (%) 55.18
Particulars MAR 2024 (Values in Cr)
Book Value / Share 216.34
ROE % 13.66
ROCE % 18.07
Total Debt to Total Equity 0.01
EBITDA Margin 14.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.24
ROE % 10.70
ROCE % 14.23
Total Debt to Total Equity 0.01
EBITDA Margin 13.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 181.14
ROE % 12.83
ROCE % 14.77
Total Debt to Total Equity 0.07
EBITDA Margin 12.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 310.59
ROE % 15.19
ROCE % 18.88
Total Debt to Total Equity 0.15
EBITDA Margin 13.47
Particulars MAR 2020 (Values in Cr)
Book Value / Share 327.03
ROE % 8.04
ROCE % 11.66
Total Debt to Total Equity 0.15
EBITDA Margin 11.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 216.51
ROE % 13.63
ROCE % 18.03
Total Debt to Total Equity 0.01
EBITDA Margin 14.51
Particulars MAR 2023 (Values in Cr)
Book Value / Share 192.42
ROE % 10.69
ROCE % 14.22
Total Debt to Total Equity 0.01
EBITDA Margin 13.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 181.30
ROE % 12.98
ROCE % 14.91
Total Debt to Total Equity 0.07
EBITDA Margin 12.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 310.39
ROE % 9.39
ROCE % 18.75
Total Debt to Total Equity 0.14
EBITDA Margin 13.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 337.66
ROE % 10.94
ROCE % 14.02
Total Debt to Total Equity 0.14
EBITDA Margin 12.66
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.94
Total Assets 626.20
Total Liabilities 626.20
Total Equity 449.93
Share Outstanding 20798575
Price to Book Ratio 2.37
Return on Assets (%) 9.29
Return on Capital (%) 12.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.45
Total Assets 528.97
Total Liabilities 528.97
Total Equity 402.27
Share Outstanding 20926628
Price to Book Ratio 1.17
Return on Assets (%) 8.05
Return on Capital (%) 10.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 113.82
Total Assets 491.01
Total Liabilities 491.01
Total Equity 394.77
Share Outstanding 21794375
Price to Book Ratio 1.16
Return on Assets (%) 7.75
Return on Capital (%) 9.5
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 31.11
Total Assets 296.12
Total Liabilities 296.12
Total Equity 199.11
Share Outstanding 6411063
Price to Book Ratio 0.00
Return on Assets (%) 5.34
Return on Capital (%) 6.87
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 18.38
Total Assets 338.48
Total Liabilities 338.48
Total Equity 209.65
Share Outstanding 6411063
Price to Book Ratio 0.00
Return on Assets (%) 4.78
Return on Capital (%) 6.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 30.89
Total Assets 626.15
Total Liabilities 626.15
Total Equity 450.29
Share Outstanding 20798575
Price to Book Ratio 2.37
Return on Assets (%) 9.28
Return on Capital (%) 12.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 25.45
Total Assets 529.00
Total Liabilities 529.00
Total Equity 402.66
Share Outstanding 20926628
Price to Book Ratio 1.17
Return on Assets (%) 8.06
Return on Capital (%) 10.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 113.80
Total Assets 491.02
Total Liabilities 491.02
Total Equity 395.12
Share Outstanding 21794375
Price to Book Ratio 1.16
Return on Assets (%) 7.85
Return on Capital (%) 9.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 30.95
Total Assets 295.99
Total Liabilities 295.99
Total Equity 198.99
Share Outstanding 6411063
Price to Book Ratio 0.00
Return on Assets (%) 1.69
Return on Capital (%) 2.18
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 18.38
Total Assets 343.80
Total Liabilities 343.80
Total Equity 216.47
Share Outstanding 6411063
Price to Book Ratio 0.00
Return on Assets (%) 6.53
Return on Capital (%) 9.41
Particulars MAR 2024 (Values in Cr)
Net Income 77.09
Cash from Operations 127.60
Cash from Investing -92.06
Cash from Financing -15.29
Net change in Cash 1.60
Free Cash Flow 165.29
Particulars MAR 2023 (Values in Cr)
Net Income 57.03
Cash from Operations 70.68
Cash from Investing -14.11
Cash from Financing -43.73
Net change in Cash 3.11
Free Cash Flow 141.57
Particulars MAR 2022 (Values in Cr)
Net Income 45.56
Cash from Operations 18.01
Cash from Investing -154.57
Cash from Financing 130.08
Net change in Cash -15.36
Free Cash Flow 32.81
Particulars MAR 2021 (Values in Cr)
Net Income 21.74
Cash from Operations 17.98
Cash from Investing -20.19
Cash from Financing 0.77
Net change in Cash -7.96
Free Cash Flow 23.83
Particulars MAR 2020 (Values in Cr)
Net Income 24.66
Cash from Operations 38.43
Cash from Investing -14.34
Cash from Financing -5.44
Net change in Cash 5.22
Free Cash Flow 53.74
Particulars MAR 2024 (Values in Cr)
Net Income 77.02
Cash from Operations 127.53
Cash from Investing -92.06
Cash from Financing -15.28
Net change in Cash 1.55
Free Cash Flow 165.21
Particulars MAR 2023 (Values in Cr)
Net Income 57.05
Cash from Operations 70.69
Cash from Investing -14.11
Cash from Financing -43.73
Net change in Cash 3.13
Free Cash Flow 141.58
Particulars MAR 2022 (Values in Cr)
Net Income 46.03
Cash from Operations 17.87
Cash from Investing -154.30
Cash from Financing 130.08
Net change in Cash -15.22
Free Cash Flow 32.67
Particulars MAR 2021 (Values in Cr)
Net Income 11.18
Cash from Operations 17.98
Cash from Investing -20.19
Cash from Financing 0.77
Net change in Cash -7.96
Free Cash Flow 23.82
Particulars MAR 2020 (Values in Cr)
Net Income 30.57
Cash from Operations 34.33
Cash from Investing -9.15
Cash from Financing -6.48
Net change in Cash 5.22
Free Cash Flow 44.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.37 31.25 2.96 416.66 37.54 / 77.70
BLISS GVS PHARMA LTD 129.00 16.15 1.34 1358.40 92.25 / 148.95
CIPLA LTD 1465.65 25.64 4.17 118365.23 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 326.85 113.49 3.31 961.95 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 54.37 47.28 9.24 416.66 37.54 / 77.70
AMRUTAJAN HEALTH LTD 706.05 42.95 6.85 2041.24 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6288.90 122.14 23.14 15722.25 4050.15 / 8139.85
BLISS GVS PHARMA LTD 129.00 16.80 1.32 1358.40 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 965.90
  • 26 Days 1006.20
  • 10 Days 998.30
  • 50 Days 968.90
  • 12 Days 1011.50
  • 100 Days 890.60
  • 20 Days 1001.80
  • 200 Days 532.60
944.30
PIVOT
First Resistance 967.30
Second Resistance 1008.00
Third Resistance 1031.00
First Support 903.60
Second Support 880.60
Third Support 839.90
RSI 42.04
MACD 5.32
Commodity Channel Index (CCI) -108.19
ADX 24.06
Williams % R -98.09

Over 1 Month

down

-7.61

Over 3 Months

down

12.45

Over 6 Months

down

52.41

Over 1 Year

down

113.37

Over 3 Years

down

48.83

Over 5 Years

down

0.00

WINDLAS BIOTECH LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

WINDLAS BIOTECH LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
27.91
Promoter Holdings
62.51
FII
1.99
DII
7.57
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Akw Wbl Family Private Trust (through Its Trustees Ashok Vimla Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 8381340.0 40.1
Ashok Kumar Windlass Shareholding of Promoter and Promoter Group 4400000.0 21.05
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund Public Shareholding 1406829.0 6.73
Vimla Windlass Shareholding of Promoter and Promoter Group 284000.0 1.36
Perpetuity Health To Wealth (h2w) Rising Fund Public Shareholding 270000.0 1.29
Prachi Jain Windlass Shareholding of Promoter and Promoter Group 3.0 0.0
Payal Windlass Shareholding of Promoter and Promoter Group 3.0 0.0
Manoj Kumar Windlass Shareholding of Promoter and Promoter Group 3.0 0.0
Hitesh Windlass Shareholding of Promoter and Promoter Group 3.0 0.0

WINDLAS BIOTECH LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-09-17 5.5 Final 2024-09-17 Equity shares 2023-09-05 4.0 Final 2023-09-05 Equity shares 2022-09-09 3.5 Final 2022-09-12 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About WINDLAS BIOTECH LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by WINDLAS BIOTECH LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Windlas Biotech Ltd?

Answer Field

The share price of Windlas Biotech Ltd for NSE is ₹ 961.7 and for BSE is ₹ 966.

What is the Market Cap of Windlas Biotech Ltd?

Answer Field

The market cap of Windlas Biotech Ltd for NSE is ₹ 20,00.19 Cr. and for BSE is ₹ 20,09.14 Cr. as of now.

What is the 52 Week High and Low of Windlas Biotech Ltd?

Answer Field

The 52 Week High and Low of Windlas Biotech Ltd for NSE is ₹ 1198.25 and ₹ 400.10 and for BSE is ₹ 1197.00 and ₹ 397.90.

How to Buy Windlas Biotech Ltd share?

Answer Field

You can trade in Windlas Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Windlas Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 113.37%.

What is the Current Share Price of Windlas Biotech Ltd?

Answer Field

Windlas Biotech Ltd share price is for NSE ₹ 961.7 & for BSE ₹ 966 as on Nov 22 2024 03:30 PM.

What is the Market Cap of Windlas Biotech Ltd Share?

Answer Field

The market cap of Windlas Biotech Ltd for NSE ₹ 20,00.19 & for BSE ₹ 20,09.14 as on Nov 22 2024 03:30 PM.

What is the P/E Ratio of Windlas Biotech Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM the price-to-earnings (PE) ratio for Windlas Biotech Ltd share is 31.61.

What is the PB ratio of Windlas Biotech Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM, the price-to-book (PB) ratio for Windlas Biotech Ltd share is 225.62.

How to Buy Windlas Biotech Ltd Share?

Answer Field

You can trade in Windlas Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Windlas Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Windlas Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Windlas Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader